Mayim Bialik, an actress, author, and neuroscientist, who became a fan-favorite on the hit CBS show The Big Bang Theory as Sheldon's quirky love interest, is starring in a sitcom of her own again. 

The show, which premiered in January and titled Call Me Kat, is about a woman who uses her life savings to open a cat cafe in Louisville, Ky. Jim Parsons, who starred opposite Bialik in The Big Bang Theory as the highly intelligent but often irritating Sheldon, is producing the show adapted from the British sitcom Miranda by Miranda Hart.

"He said 'if anyone can pull off annoying but also adorable, I think it's you," Bialik told Cheddar. 

In the grand-old tradition of adapting British comedies, the two shows will share more in spirit than in specifics, but both concern a single woman looking for love and employment. What's unique to the American version is the decision to base the show in a cat cafe. 

Luckily for Bialik, she's a cat owner herself. 

"It's really awesome that I get to play with cats all day at work, and come home and then deal with my own cats who definitely smell the other cats on me," she said.

A stylistic choice that was carried over from Miranda is that Bialik's character will break the fourth wall throughout the show. 

"Kat is a character who's alone a lot and tries not to be lonely, so the audience is kind of in on what's going on in her head," Bialik said. 

In addition, the cast takes a bow at the end of each episode, which Bialik said has been divisive. 

"You don't have to love it, but if you don't, it's not our fault. It's based on Miranda," she said.

The neuroscientist also took a moment to talk about the world outside the silver screen.  

Bialik made headlines back in October for posting a video on YouTube clarifying that she was not an anti-vaxxer. She said misinformation had spread about her because her newly-born children were not vaccinated on a regular schedule. 

"Obviously my children are vaccinated," she said. "We are a family that supports the vaccine program for this virus." 

However, she noted that she was a skeptical person in general and pointed out that the long-term effects of COVID vaccines are still unknown. Nonetheless, she said she got the vaccine in order to reach herd immunity as soon as possible. 

"I got the vaccine, and that's something that I decided to share about because there's been a lot of misinformation about me." 

Share:
More In Culture
Arming Teachers Is 'Insane': Teachers Union Chief
Education Sec. Betsy Devos's idea to use federal money to arm teachers is "insane," said Randy Weingarten, president of the American Federation of Teachers. "I cannot believe I'm actually talking about this," she said.
Allow J. Crew to Reintroduce Itself
The icon of American preppy style is remaking itself as a more accessible brand. But in an era of shifting retail trends, will it work? GQ fashion reporter Cam Wolf gives his take.
Rep. Carolyn Maloney Takes on the Pink Tax
Rep.Carolyn Maloney (D-NY) released a report titled "Earn Less, Pay More," that highlights the cost discrepancies between women's and men's products. She spoke to Cheddar about her findings on Women's Equality Day.
Opening Bell: August 28, 2018
Canadian Foreign Minister Chrystia Freeland is headed to Washington to continue trade negotiations with the U.S. On Monday, Mexico and the United States agreed to terms for a new trade deal. Electronic Arts is canceling three qualifier events for its 'Madden NFL 19' tournament in the wake of Sunday's deadly shooting in Jacksonville, Florida. The company says it will conduct a review of safety measures to ensure the security of competitors and spectators. And Kathy Ireland, Chairman Emeritus and Chief Brand Strategist at Level Brands, joins Cheddar after ringing the Opening Bell Tuesday morning. She talks about what has driven the recent success of Level Brands, a brand management and licensing company.
Kathy Ireland Talks Her Brand's Step Into CBD
Kathy Ireland, Chief Brand Strategist of Level Brands, spoke with Cheddar about her company's dive into the CBD market. Shares of cannabis companies have been soaring as momentum grows for wide marijuana legalization.
Load More